The stable liquid glucagon is loaded in a prefilled, ready-to-use autoinjector and has been successfully tested across multiple Phase 3 studies during conditions of insulin-induced severe hypoglycemia.18,19 The autoinjector offers the potential for easy, rapid injection of a full dose of glucagon during emergencies and further reduces fear and anxiety for both the patient and caregiver. This evidence concerns the gene INS and Hypoglycemia.